Akums signs Rs. 1,760 crore CDMO agreement with a leading global pharma company
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
This product is categorized as antacids, antiflatulents and anti-Ulcerants
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
e brings over 27+ years of rich pharmaceutical experience
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Subscribe To Our Newsletter & Stay Updated